Ig Vena

Human Normal Immunoglobulin, the active ingredient in Ig Vena, is an immunoglobulin presented as a solution for injection for intravenous use. It treats primary and secondary immunodeficiency diseases and hypogammaglobulinemia in patients with deficient endogenous IgG.

GNH USA supplies Ig Vena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Ig Vena is an intravenous immunoglobulin used to replace deficient antibodies in various immunodeficiency conditions.

Primary immunodeficiency diseases: provides IgG replacement to reduce the frequency and severity of infections. Secondary immunodeficiency: restores immune competence in patients with acquired IgG deficiency, such as after chemotherapy. Hypogammaglobulinemia: supplies missing antibodies to maintain protective immunity and prevent recurrent infections.

Ig Vena may be associated with a range of adverse reactions following intravenous administration.

Common Side Effects: - Headache - Fever or chills - Nausea - Fatigue - Mild infusion‑related erythema or itching - Transient hypotension

Serious or Rare Side Effects: - Anaphylactic or severe allergic reactions - Hemolytic anemia - Thromboembolic events - Acute renal dysfunction - Aseptic meningitis - Severe hypotension or cardiovascular collapse

When using Ig Vena, clinicians should observe several safety measures.

Allergic reaction monitoring: watch for signs of anaphylaxis during and after infusion. Renal function assessment: evaluate baseline kidney function and adjust infusion volume as needed. IgA deficiency screening: test for anti‑IgA antibodies to reduce risk of severe reactions. Infusion rate control: start slowly and increase gradually, especially in patients with cardiovascular disease. Fluid overload vigilance: monitor patients with heart failure or pulmonary edema. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ig Vena can interact with other therapies, requiring careful management.

Major Interactions (Avoid): - Live attenuated vaccines: may cause uncontrolled infection due to altered immune response. - Concurrent use of other immunoglobulin products: can lead to excessive IgG levels and increased viscosity.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): increased risk of bleeding due to volume load. - ACE inhibitors or ARBs: potential for additive hypotensive effects. - Diuretics: may exacerbate fluid shifts and affect renal clearance. - Immunosuppressants: heightened infection risk, requiring dose adjustments.